Brief: Evoke Pharma Reports First Quarter 2023 Financial Results
15/05/2023 22:23
Evoke Pharma Inc EVOK.O :
* EVOKE PHARMA REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
* EVOKE PHARMA INC- QTRLY LOSS PER SHARE $0.67
* EVOKE PHARMA INC - AS OF MARCH 31, 2023, CASH AND CASH
EQUIVALENTS WERE APPROXIMATELY $8.2 MILLION
* EVOKE PHARMA INC - BELIEVE, EXISTING CASH AND CASH
EQUIVALENTS
WILL BE SUFFICIENT TO FUND OUR OPERATIONS INTO Q4 OF 2023
Source text for Eikon: ID:nGNXbRLcSq
Further company coverage: EVOK.O
Recent news on Evoke Pharma
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Evoke Pharma Q3 sales rise 61%, expects QOL Medical acquisition to close in Q4 2025
Brief: Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
Evoke Pharma Inc reports results for the quarter ended June 30 - Earnings Summary